Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression?
J Clin Psychiatry
; 81(1)2020 Jan 28.
Article
in En
| MEDLINE
| ID: mdl-31995676
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Administration Routes
/
Depressive Disorder, Treatment-Resistant
/
Ketamine
/
Antidepressive Agents
Type of study:
Etiology_studies
Limits:
Humans
Language:
En
Journal:
J Clin Psychiatry
Year:
2020
Document type:
Article
Country of publication:
United States